Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Carroll

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Virology|December 5, 1998
Marker rescue of the host range restriction defects of modified vaccinia virus AnkaraL S Wyatt, M W Carroll, C P Czerny, et al.
Journal of the National Cancer Institute|December 23, 1998
Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigenM W Carroll, W W Overwijk, D R Surman, et al.
Vaccine|March 1, 1997
Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor modelM W Carroll, W W Overwijk, R S Chamberlain, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 12, 2013
The continued emergence of hantaviruses: isolation of a Seoul virus implicated in human disease, United Kingdom, October 2012L J Jameson, C H Logue, B Atkinson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expressionJ B Rao, R S Chamberlain, V Bronte, et al.
Biochimica Et Biophysica Acta|December 13, 2000
Isolation of a high affinity scFv from a monoclonal antibody recognising the oncofoetal antigen 5T4D M Shaw, M J Embleton, C Westwater, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1997
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccineV Bronte, M W Carroll, T J Goletz, et al.
Cancer Research|June 15, 1996
Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccinesR S Chamberlain, M W Carroll, V Bronte, et al.
Human Vaccines & Immunotherapeutics|August 27, 2015
A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal diseaseS D Dowall, K R Buttigieg, S J D Findlay-Wilson, et al.
European Journal of Clinical Nutrition|February 3, 2018
Vitamin D status and risk for sarcopenia in youth with inflammatory bowel diseasesD R Mager, M W Carroll, E Wine, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Virology|December 5, 1998
Marker rescue of the host range restriction defects of modified vaccinia virus AnkaraL S Wyatt, M W Carroll, C P Czerny, et al.
Journal of the National Cancer Institute|December 23, 1998
Construction and characterization of a triple-recombinant vaccinia virus encoding B7-1, interleukin 12, and a model tumor antigenM W Carroll, W W Overwijk, D R Surman, et al.
Vaccine|March 1, 1997
Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor modelM W Carroll, W W Overwijk, R S Chamberlain, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 12, 2013
The continued emergence of hantaviruses: isolation of a Seoul virus implicated in human disease, United Kingdom, October 2012L J Jameson, C H Logue, B Atkinson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expressionJ B Rao, R S Chamberlain, V Bronte, et al.
Biochimica Et Biophysica Acta|December 13, 2000
Isolation of a high affinity scFv from a monoclonal antibody recognising the oncofoetal antigen 5T4D M Shaw, M J Embleton, C Westwater, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1997
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccineV Bronte, M W Carroll, T J Goletz, et al.
Cancer Research|June 15, 1996
Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccinesR S Chamberlain, M W Carroll, V Bronte, et al.
Human Vaccines & Immunotherapeutics|August 27, 2015
A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal diseaseS D Dowall, K R Buttigieg, S J D Findlay-Wilson, et al.
European Journal of Clinical Nutrition|February 3, 2018
Vitamin D status and risk for sarcopenia in youth with inflammatory bowel diseasesD R Mager, M W Carroll, E Wine, et al.
Pageof 4